<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04030754</url>
  </required_header>
  <id_info>
    <org_study_id>257/RC/KEMU</org_study_id>
    <nct_id>NCT04030754</nct_id>
  </id_info>
  <brief_title>Comparison of Effectiveness of Amniotic Membrane and Duoderm Dressings in Pediatric Burns</brief_title>
  <official_title>Comparison of Effectiveness of Amniotic Membrane and Duoderm Dressings in Pediatric Burn Patients: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Edward Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Edward Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a difference in frequency of wound infection, mean pain score, mean of time for skin
      grafting and hospital stay in pediatric 2nd and 3rd degree burns, between amniotic membrane
      and duoderm dressings
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After informed consent of the patients, patients who will fulfill the inclusion and exclusion
      criteria will be enrolled in the study from Department of Pediatric Surgery, Mayo Hospital
      Lahore and will be randomly allocated by lottery method into 2 groups by the doctor. Group A
      and B with 86 patients in each group. Group A patients will be undergoing amniotic membrane
      dressing, while group B patients will undergo colloid gel foam dressing. Basic demographic
      information will be noted. Effect modifiers (hemoglobin level, weight and height) will be
      noted.

      In group A, the wounds will be washed with normal saline and then covered with amniotic
      membrane over which a layer of Vaseline gauze will be applied and dressing with gauze and the
      crape bandage will be applied. Every 3-4 days these dressings will be changed and assessed
      for pain, wound infection and wound c/s will be sent. Placentas from clean vaginal deliveries
      and elective C-sections will be taken. Blood of mother will be screened. Amniotic membrane
      will be separated from placenta in a clean sterile bowl. Bowl will be put in refrigerator at
      4 degrees.

      In group B, wound will be washed with normal saline . The wound site will be covered with
      Colloid Gel Foam and gauze, and crape bandage will be applied. Dressing will be changed after
      3-4 days. The outcome (pain score, wound infection,time for skin grafting and hospital stay)
      will be compared in both groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 24, 2019</start_date>
  <completion_date type="Anticipated">February 14, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 14, 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mean time for skin grafting</measure>
    <time_frame>average time will be 21 days</time_frame>
    <description>time for grafting when wound has healthy granulation tissue</description>
  </primary_outcome>
  <primary_outcome>
    <measure>frequency of wound infection</measure>
    <time_frame>at 5th day of dressing</time_frame>
    <description>redness around burnt wound, tenderness, swelling, increased temperature (&gt;4 degrees), exudation and growth on wound cultures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mean of hospital stay</measure>
    <time_frame>at the time of discharge, that can be from 7th day to 30th day</time_frame>
    <description>time at which patient wound is completely healed and no wound infection present, average time will be up to 30 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mean of pain for patients of age &lt;8 years assessed by Visual Analogue Score</measure>
    <time_frame>at 5th day of dressing change</time_frame>
    <description>pain will be assessed at the time of dressing change. for patients&lt;8 years of age visual analogue score will be used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mean of pain for patients of age &gt;8 years assessed by Face, Leg, Activity, Cry, Consolabilty Pain Scale.</measure>
    <time_frame>at 5th day of dressing change</time_frame>
    <description>FLACC (face,leg, activity, cry, consolability) pain scale will be used</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">172</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>amniotic membrane group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>amniotic dressing will be applied to these patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>duoderm group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>duoderm dressing will be applied to these patients as intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>amniotic membrane</intervention_name>
    <description>amniotic membrane is a biological dressing</description>
    <arm_group_label>amniotic membrane group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>duoderm dressing</intervention_name>
    <description>duoderm dressing is a synthetic dressing</description>
    <arm_group_label>duoderm group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  10-45 % percent 2nd and 3rd degree fresh burns age less than 12 years patients of both
             gender

        Exclusion Criteria:

          -  patients whose parents are not willing patients whose wound c/s comes positive at the
             time of admission patients who have associated medical disorder and trauma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>fatima naumeri, mbbs, fcps</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Edward Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>fatima naumeri, mbbs, fcps</last_name>
    <phone>+923214017065</phone>
    <email>fatimanaumeri@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>bilal qayyum, mbbs</last_name>
    <phone>+923314146435</phone>
    <email>bilalqayyum17690@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>King Edward Medical University</name>
      <address>
        <city>Lahore</city>
        <state>Punjab</state>
        <zip>54000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irshad hussain, mbbs</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Eskandarlou+M%2C+Azimi+M%2C+Rabiee+S+and+Rabiee+MA</url>
    <description>about method of preparation and application of amniotic membrane</description>
  </link>
  <reference>
    <citation>Al Ibran E, Mirza FH, Memon AA, Farooq MZ, Hassan M. Mortality associated with burn injury - a cross sectional study from Karachi, Pakistan. BMC Res Notes. 2013 Dec 19;6:545. doi: 10.1186/1756-0500-6-545.</citation>
    <PMID>24354896</PMID>
  </reference>
  <reference>
    <citation>Mohammadi AA, Johari HG, Eskandari S. Effect of amniotic membrane on graft take in extremity burns. Burns. 2013 Sep;39(6):1137-41. doi: 10.1016/j.burns.2013.01.017. Epub 2013 Mar 21.</citation>
    <PMID>23523222</PMID>
  </reference>
  <reference>
    <citation>Martin FT, O'Sullivan JB, Regan PJ, McCann J, Kelly JL. Hydrocolloid dressing in pediatric burns may decrease operative intervention rates. J Pediatr Surg. 2010 Mar;45(3):600-5. doi: 10.1016/j.jpedsurg.2009.09.037.</citation>
    <PMID>20223327</PMID>
  </reference>
  <reference>
    <citation>Eskandarlou M, Azimi M, Rabiee S, Seif Rabiee MA. The Healing Effect of Amniotic Membrane in Burn Patients. World J Plast Surg. 2016 Jan;5(1):39-44.</citation>
    <PMID>27308239</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 26, 2019</study_first_submitted>
  <study_first_submitted_qc>July 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2019</study_first_posted>
  <last_update_submitted>February 20, 2020</last_update_submitted>
  <last_update_submitted_qc>February 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Edward Medical University</investigator_affiliation>
    <investigator_full_name>Fatima Numeri</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>pediatric burns, dressings, amniotic membrane, duoderm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

